Clinical Trial Update: X-82 to Treat Age-related Macular Degeneration [Phase 2]

View source ↗

Summary

Phase 2 trial of X-82 for age-related macular degeneration has been terminated; results were posted in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Age-related Macular Degeneration
• Exudative Age-related Macular Degeneration
• Macular Degeneration Age-related

Drugs mentioned

• X-82

Snippet

Sponsor: Tyrogenex | Conditions: Age-Related Macular Degeneration (AMD), Macular Degeneration | Phase 2 | Status: TERMINATED | Results posted: 2018-06-27